Newbury Pharmaceuticals AB (NEWBRY)
Market Open
15 Oct, 03:25 PM
XSTO XSTO Primary kr
2. 08
-0.11
-5.0228%
kr
30.28M Market Cap
- P/E Ratio
- Div Yield
29,844 Volume
0 Eps
kr 2.19
Previous Close Want to track NEWBRY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Newbury Pharmaceuticals AB (NEWBRY) Statistics
Valuation metrics
Market Cap 30.28M
Enterprise value 57.29M
Trailing P/E (ttm) -2.68
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 16.61
Price/Book (mrq) 1.7
Enterprise Value/Revenue 16.61
Enterprise Value/EBITDA -3.01
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 24.66K
Average volume (90 days) 33.53K
Price summary
52-Week low 0.76
52-Week high 3.04
Beta -
50-Day moving average 2.35
200-Day moving average 1.99
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.85%
Operating margin -6.79%
Operational effectiveness
Return on assets -0.29%
Return on equity -0.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.42
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.21%
Book value per share (mrq) 1.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
